FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NYSE Alternext: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced that the Company received notice from the NYSE Alternext US LLC (NYSE Alternext US) that the NYSE Alternext US has granted the Company an extension until April 17, 2009 to regain compliance with Section 1003(a)(iv) of the NYSE Alternext US Company Guide. The Company’s deadline to regain compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE Alternext US Company Guide remains November 16, 2009.
